Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Côté, Marceline ^b,c   Zheng, Yi Min ^a   Liu, Shan Lu ^a,b  

^a University of Missouri   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; PROTEINASE; PROTEINASE INHIBITOR; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR; VIRUS RECEPTOR XPR1;

ANIMAL CELL; ARTICLE; CELL FUSION; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; CYTOPLASMIC TAIL; GENE OVEREXPRESSION; MEMBRANE FUSION; NONHUMAN; PH; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; VIRAL GENE DELIVERY SYSTEM; VIRUS ENTRY; VIRUS INFECTION; VIRUS SHEDDING; XENOTROPIC MULV RELATED VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CRICETINAE; GENE PRODUCTS, ENV; GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; LENTIVIRUS; MEMBRANE FUSION; MICE; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, VIRUS; RETROVIRIDAE; TRANSDUCTION, GENETIC; VIRUS INTERNALIZATION; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

GAMMARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 84858974932     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033734     Document Type: Article

References (66)

1. Coffin JM, Hughes SH, Varmus HE, (1997) Retroviruses New York Cold Spring Harbor Laboratory Press.
2. White JM, Delos SE, Brecher M, Schornberg K, (2008) Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Bio 43: 189-219.
3. Eckert DM, Kim PS, (2001) Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 70: 777-810.
4. Earp LJ, Delos SE, Park HE, White JM, (2005) The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 285: 25-66.
5. Quinones-Kochs MI, Buonocore L, Rose JK, (2002) Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J Virol 76: 4199-4211.
6. Côté M, Zheng YM, Albritton LM, Liu S-L, (2011) Single residues in the surface subunits of oncogenic sheep retrovirus envelopes distinguish receptor-mediated triggering for fusion at low pH and infection. Virology.
7. Knoper RC, Ferrarone J, Yan Y, Lafont BA, Kozak CA, (2009) Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage. Virology 391: 232-239.
8. Brody BA, Hunter E, (1992) Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU-TM association. J Virol 66: 3466-3475.
9. Rein A, Mirro J, Haynes JG, Ernst SM, Nagashima K, (1994) Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J Virol 68: 1773-1781.
10. Rice NR, Henderson LE, Sowder RC, Copeland TD, Oroszlan S, et al. (1990) Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus. J Virol 64: 3770-3778.
11. Januszeski MM, Cannon PM, Chen D, Rozenberg Y, Anderson WF, (1997) Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol 71: 3613-3619.
12. Green N, Shinnick TM, Witte O, Ponticelli A, Sutcliffe JG, et al. (1981) Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc Natl Acad Sci USA 78: 6023-6027.
13. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA, (2000) Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103: 679-689.
14. Ross SR, Schofield JJ, Farr CJ, Bucan M, (2002) Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proc Natl Acad Sci USA 99: 12386-12390.
15. Picard-Maureau M, Jarmy G, Berg A, Rethwilm A, Lindemann D, (2003) Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process. J Virol 77: 4722-4730.
16. Brindley MA, Maury W, (2005) Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus. J Virol 79: 14482-14488.
17. Jin S, Zhang B, Weisz OA, Montelaro RC, (2005) Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway. J Virol 79: 14489-14497.
18. Côté M, Kucharski TJ, Liu S-L, (2008) Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection. J Virol 82: 9023-9034.
19. Côté M, Zheng YM, Albritton LM, Liu S-L, (2008) Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations. J Virol 82: 2543-2554.
20. Bertrand P, Cote M, Zheng YM, Albritton LM, Liu SL, (2008) Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry. J Virol 82: 2555-2559.
21. Kumar P, Nachagari D, Fields C, Franks J, Albritton LM, (2007) Host Cell Cathepsins Potentiate Moloney Murine Leukemia Virus Infection. J Virol 81: 10506-10514.
22. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM, (2005) Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection. Science 308: 1643-1645.
23. Huang IC, Bosch BJ, Li F, Li W, Lee KH, et al. (2006) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281: 3198-3203.
24. Pager CT, Dutch RE, (2005) Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. Journal of Virology 79: 12714-12720.
25. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, et al. (2005) Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 102: 11876-11881.
26. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, et al. (2006) Role of Endosomal Cathepsins in Entry Mediated by the Ebola Virus Glycoprotein. J Virol 80: 4174-4178.
27. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
28. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
29. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, et al. (2011) Recombinant origin of the retrovirus XMRV. Science 333: 97-101.
30. Cingoz O, Paprotka T, Delviks-Frankenberry KA, Wildt S, Hu WS, et al. (2011) Characterization, Mapping and Distribution of the Two XMRV Parental Proviruses. J Virol.
31. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, et al. (2011) Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 334: 814-817.
32. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, et al. (2011) No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333: 94-97.
33. Battini JL, Rasko JE, Miller AD, (1999) A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci U S A 96: 1385-1390.
34. Tailor CS, Nouri A, Lee CG, Kozak C, Kabat D, (1999) Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A 96: 927-932.
35. Yang YL, Guo L, Xu S, Holland CA, Kitamura T, et al. (1999) Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet 21: 216-219.
36. Kozak CA, (2011) The mouse "xenotropic" gammaretroviruses and their XPR1 receptor. Retrovirology 7: 101.
37. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, et al. (2007) An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 104: 1655-1660.
38. Bhosle S, Suppiah S, Molinaro R, Liang Y, Arnold R, et al. (2011) Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells. J Virol 84: 6288-6296.
39. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, et al. (2009) Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 83: 7353-7356.
40. Yan Y, Liu Q, Wollenberg K, Martin C, Buckler-White A, et al. (2010) Evolution of functional and sequence variants of the mammalian XPR1 receptor for mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV. J Virol 84: 11970-11980.
41. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, et al. (2010) Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 399: 23-30.
42. McClure MO, Sommerfelt MA, Marsh M, Weiss RA, (1990) The pH independence of mammalian retrovirus infection. J Gen Virol 71: 767-773.
43. Liu S-L, Duh FM, Lerman MI, Miller AD, (2003) Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins. J Virol 77: 2850-2858.
44. Melikyan GB, Markosyan RM, Brener SA, Rozenberg Y, Cohen FS, (2000) Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation. J Virol 74: 447-455.
45. Côté M, Zheng YM, Liu S-L, (2009) Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion. J Virol 83: 11447-11455.
46. Melikyan GB, Brener SA, Ok DC, Cohen FS, (1997) Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol 136: 995-1005.
47. Xu W, Eiden MV, (2011) Primate gammaretroviruses require an ancillary factor not required for murine gammaretroviruses to infect BHK cells. J Virol 85: 3498-3506.
48. Checkley MA, Luttge BG, Freed EO, (2011) HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 410: 582-608.
49. Sakuma T, De Ravin SS, Tonne JM, Thatava T, Ohmine S, et al. (2011) Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Hum Gene Ther 21: 1665-1673.
50. Katen LJ, Januszeski MM, Anderson WF, Hasenkrug KJ, Evans LH, (2001) Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J Virol 75: 5018-5026.
51. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB, (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444.
52. Kamiyama H, Kakoki K, Yoshii H, Iwao M, Igawa T, et al. (2011) Infection of XC cells by MLVs and Ebola virus is endosome-dependent but acidification-independent. PLoS One 6: e26180.
53. Miller DG, Miller AD, (1992) Tunicamycin treatment of CHO cells abrogates multiple blocks to retrovirus infection, one of which is due to a secreted inhibitor. J Virol 66: 78-84.
54. Miller DG, Miller AD, (1993) Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera. J Virol 67: 5346-5352.
55. Setty MK, Devadas K, Ragupathy V, Ravichandran V, Tang S, et al. (2011) XMRV: usage of receptors and potential co-receptors. Virol J 8: 423.
56. LaBranche CC, Sauter MM, Haggarty BS, Vance PJ, Romano J, et al. (1995) A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol 69: 5217-5227.
57. Lodge R, Lalonde JP, Lemay G, Cohen EA, (1997) The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. Embo J 16: 695-705.
58. Ochsenbauer C, Dubay SR, Hunter E, (2000) The Rous sarcoma virus Env glycoprotein contains a highly conserved motif homologous to tyrosine-based endocytosis signals and displays an unusual internalization phenotype. Mol Cell Biol 20: 249-260.
59. Grange MP, Blot V, Delamarre L, Bouchaert I, Rocca A, et al. (2000) Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface. J Virol 74: 11734-11743.
60. Aguilar HC, Anderson WF, Cannon PM, (2003) Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide. J Virol 77: 1281-1291.
61. Taylor GM, Sanders DA, (2003) Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain. Virology 312: 295-305.
62. Dorairaj S, Allen TW, (2007) On the thermodynamic stability of a charged arginine side chain in a transmembrane helix. Proc Natl Acad Sci U S A 104: 4943-4948.
63. Steckbeck JD, Craigo JK, Barnes CO, Montelaro RC, (2011) Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication. J Biol Chem 286: 27156-27166.
64. Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, et al. (2005) Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol 79: 12231-12241.
65. Miller AD, Chen F, (1996) Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol 70: 5564-5571.
66. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.